John Savin
Analyst-Equity bei Equity Development Ltd.
Aktive Positionen von John Savin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Equity Development Ltd.
Equity Development Ltd. Investment ManagersFinance Equity Development Ltd. is an investment research firm headquartered in London, UK. The firm was founded by Brian Basham in 1997 and is a subsidiary of Equity Holdings Ltd., which is owned by Bashco Ltd. Equity Development provides investors of all types with freely available equity research and direct access to quoted companies’ management. | Analyst-Equity | - | - |
Proactive Investors Ltd.
Proactive Investors Ltd. Investment ManagersFinance Proactive Investors Ltd. is a financial media portal that connects companies and investors. The company is based in London, UK, and has subsidiaries in the United States. The British company provides breaking news, commentary, and analysis on hundreds of listed companies and pre-IPO businesses globally, 24/7. The company offers in-depth comment, analysis, press releases, and share price data on small to large capitalized companies. Proactive is one of the fastest-growing financial media portals in the world, leading in up-to-the-minute, multi-media news provision, events organization, and investor research. The company was founded in 2006 by Craig Ribton, who has been the CEO since 2006. | Analyst-Equity | - | - |
Karriereverlauf von John Savin
Ehemalige bekannte Positionen von John Savin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Edison Investment Research Ltd.
Edison Investment Research Ltd. Investment ManagersFinance Edison Investment Research Ltd. (Edison) is an investment research, investor relations and consulting firm headquartered in London, UK. The firm was founded by Stephen Rogers and Fraser Thorne in 2003. They are a subsidiary of Edison Global Ltd. Edison provides investment research to international investors, advisors and stakeholders. | Analyst-Equity | 01.09.2009 | 01.10.2021 |
PHYSIOMICS PLC | Präsident | 26.07.2001 | 08.06.2006 |
Genova Biotherapeutics, Inc.
Genova Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Genova Biotherapeutics, Inc. is a biotechnological drug development company with a focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings. The company currently holds rights to pending patent applications for three medicines. Patent applications for each of the three drugs are Prostate cancer treatment & Breast cancer treatment. Prostate cancer treatment relates to the use of short polypeptides for treatment of cancers and more particular for the treatment of prostate cancer. Breast cancer treatment provides treatment for patients suffering from cancer and more preferably from breast cancer using new lipid derivatives such as tetanolic acid. The company was founded in December 6, 2005 and is headquartered in New York, NY. | Corporate Officer/Principal | 15.04.2009 | - |
City Capital Corp. Ltd.
City Capital Corp. Ltd. Investment Banks/BrokersFinance City Capital Corp. Ltd. provides brokerage services. The private company is based in London, UK. and has subsidiaries in Bermuda. The British company was founded in 2002. David C. Meacher has been the CEO of the company since 2003. | Analyst-Equity | 08.05.2008 | - |
Statistik
International
Vereinigtes Königreich | 6 |
Vereinigte Staaten | 2 |
Operativ
Analyst-Equity | 4 |
President | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Finance | 5 |
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHYSIOMICS PLC | Commercial Services |
Private Unternehmen | 5 |
---|---|
City Capital Corp. Ltd.
City Capital Corp. Ltd. Investment Banks/BrokersFinance City Capital Corp. Ltd. provides brokerage services. The private company is based in London, UK. and has subsidiaries in Bermuda. The British company was founded in 2002. David C. Meacher has been the CEO of the company since 2003. | Finance |
Genova Biotherapeutics, Inc.
Genova Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Genova Biotherapeutics, Inc. is a biotechnological drug development company with a focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings. The company currently holds rights to pending patent applications for three medicines. Patent applications for each of the three drugs are Prostate cancer treatment & Breast cancer treatment. Prostate cancer treatment relates to the use of short polypeptides for treatment of cancers and more particular for the treatment of prostate cancer. Breast cancer treatment provides treatment for patients suffering from cancer and more preferably from breast cancer using new lipid derivatives such as tetanolic acid. The company was founded in December 6, 2005 and is headquartered in New York, NY. | Health Technology |
Edison Investment Research Ltd.
Edison Investment Research Ltd. Investment ManagersFinance Edison Investment Research Ltd. (Edison) is an investment research, investor relations and consulting firm headquartered in London, UK. The firm was founded by Stephen Rogers and Fraser Thorne in 2003. They are a subsidiary of Edison Global Ltd. Edison provides investment research to international investors, advisors and stakeholders. | Finance |
Equity Development Ltd.
Equity Development Ltd. Investment ManagersFinance Equity Development Ltd. is an investment research firm headquartered in London, UK. The firm was founded by Brian Basham in 1997 and is a subsidiary of Equity Holdings Ltd., which is owned by Bashco Ltd. Equity Development provides investors of all types with freely available equity research and direct access to quoted companies’ management. | Finance |
Proactive Investors Ltd.
Proactive Investors Ltd. Investment ManagersFinance Proactive Investors Ltd. is a financial media portal that connects companies and investors. The company is based in London, UK, and has subsidiaries in the United States. The British company provides breaking news, commentary, and analysis on hundreds of listed companies and pre-IPO businesses globally, 24/7. The company offers in-depth comment, analysis, press releases, and share price data on small to large capitalized companies. Proactive is one of the fastest-growing financial media portals in the world, leading in up-to-the-minute, multi-media news provision, events organization, and investor research. The company was founded in 2006 by Craig Ribton, who has been the CEO since 2006. | Finance |
- Börse
- Insiders
- John Savin
- Erfahrung